Christopher Brett Primiano, EVP, CBO, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 77,821 shares at $16.85 ($1.3M) on 2020-10-13, disclosed to the SEC on 2020-10-14.
Open-market sale of $1.3M KPTI by EVP, CBO, GC & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.85 | 38,550 | $650K | 49.5% |
| 2 | $16.85 | 38,550 | $650K | 49.5% |
| 3 | $17.20 | 721 | $12K | 0.9% |
| Total | $16.85 avg | 77,821 | $1.3M | 100% |
| Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |
| KPTI | SELL | 2020-03-04 | $672K | — | Filing → |